(Q43008709)

12 November 2017

title

Cardiovascular safety assessments in the conscious telemetered dog: utilisation of super-intervals to enhance statistical power (English)

1 reference

12 November 2017

1 reference

A Sivarajah

1

1 reference

12 November 2017

S Collins

2

1 reference

12 November 2017

M R Sutton

3

1 reference

12 November 2017

N Regan

4

1 reference

12 November 2017

H West

5

1 reference

12 November 2017

M Holbrook

6

1 reference

12 November 2017

N Edmunds

7

1 reference

12 November 2017

publication date

4 June 2010

1 reference

Journal of Pharmacological and Toxicological Methods

12 November 2017

published in

1 reference

12 November 2017

volume

62

1 reference

12 November 2017

issue

1

1 reference

12 November 2017

page(s)

12-19

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.05.011

12 November 2017

1 reference

A highly sensitive canine telemetry model for detection of QT interval prolongation: studies with moxifloxacin, haloperidol and MK-499

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.05.011

ILSI-HESI cardiovascular safety subcommittee dataset: an analysis of the statistical properties of QT interval and rate-corrected QT interval (QTc).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.05.011

Statistical power analysis for hemodynamic cardiovascular safety pharmacology studies in beagle dogs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.05.011

Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.05.011

Anatomy of the pig heart: comparisons with normal human cardiac structure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.05.011

Electrocardiogram, hemodynamics, and core body temperatures of the normal freely moving laboratory beagle dog by remote radiotelemetry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.05.011

Developing a strategy for the nonclinical assessment of proarrhythmic risk of pharmaceuticals due to prolonged ventricular repolarization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.05.011

A pharmacokinetic-pharmacodynamic model for the quantitative prediction of dofetilide clinical QT prolongation from human ether-a-go-go-related gene current inhibition data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.05.011

Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.05.011

Heart rate and cardiovascular mortality: the Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.05.011

Optimizing the experimental environment for dog telemetry studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.05.011

Monotherapy versus combination drug therapy for the treatment of benign prostatic hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.05.011

A novel propellant-free inhalation drug delivery system for cardiovascular drug safety evaluation in conscious dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.05.011

Blood pressure and risk of secondary cardiovascular events in women: the Women's Antioxidant Cardiovascular Study (WACS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.05.011

An optimised neurobehavioural observation battery integrated with the assessment of cardiovascular function in the beagle dog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.05.011

Pharmacokinetic-pharmacodynamic modeling of drug-induced effect on the QT interval in conscious telemetered dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.05.011

A call for more integrated cardiovascular safety assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.05.011

Blood-pressure lowering for the secondary prevention of stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.05.011

Evaluation of cardiovascular and ECG parameters in the normal, freely moving Göttingen Minipig

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.05.011

Correction of QT values to allow for increases in heart rate in conscious Beagle dogs in toxicology assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.05.011

Evaluation of blood flow parameters in addition to blood pressure and electrocardiogram in the conscious telemetered beagle dog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.05.011

QT PRODACT: in vivo QT assay in the conscious dog for assessing the potential for QT interval prolongation by human pharmaceuticals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.05.011

Integrated risk assessment and predictive value to humans of non-clinical repolarization assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.05.011

Doxazosin in the current treatment of hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.05.011

10.1016/J.VASCN.2010.05.011

7 January 2021

Identifiers

DOI

1 reference

12 November 2017

1 reference